Selling Sickness examines how major pharmaceutical companies shape medical research, diagnostic thresholds and public perception to expand what counts as illness. The book argues that redefining mild or common complaints can produce new patients and new markets.

Using concrete examples—allergic sniffles relabeled as allergic rhinitis, cyclical mood changes framed as psychiatric disorders, and childhood hyperactivity recast as attention-deficit diagnoses—the authors trace how diagnostic expansion affects prescribing, patient identity and public spending.

This Canadian edition includes an introduction on the implications for Canada's healthcare system, making the book relevant to consumers, clinicians and policy makers concerned with medicalization and health policy reform.

Topics covered

• Pharma marketing and medical research
• Diagnosis expansion and overprescribing
• Health policy and system costs

We ship at a flat rate of $9.99 per order. Orders $45 and up ship free of charge.